i-Target

Challenges and Opportunities for Pancreatic Cancer Immunotherapy dlvr.it/Rndj8P

Last seminar of 2020! Great results colloquium from Magdalena Zaucha on the influence of genetic factors on immune response to Yellow Fever vaccination! Thank you, @magdalenazaucha!

#CARTcell Therapie News vom #ASH20. Beim #ASHToday zusammengefasst von Prof. Peter Bader von der Uniklinik Frankfurt, Prof. Andreas Mackensen von der Uniklinik Erlangen, Prof. @MSubklewe vom @LMU_Uniklinikum und Prof. Simone Thomas von der @presse_ukr 👉 ash-today.de!

On the second day it was a pleasure to learn more about the Roll of RNA in Cancer. A big "thank you" to our speakers Prof. Dr. Sven Diederichs, Dr. Gunhild Sommer, Prof. Dr. Gunter Meister, and Dr. Markus Krentz for their very nice and informative talks!

On the first day we had a lot of fun with our trainer Dr. Daniel Mertens at the very encouraging "Scientists Need More! Grant Writing and Getting Funded" Soft Skill workshop!

Last week the students enjoyed two days at the the i-Target fall workshop (virtually of course). (Thread)

Weekly seminar Very insightful talk given by our guest speaker, Dr. Carsten Marr from the Institute of Computational Biology, @HelmholtzMunich on artificial intelligence in computational hematopathology. Thank you, @MarrCarsten!

Weekly seminar Great results colloquium by @AnneMarieSenz on the impact of IDO1 depletion in adoptive T cell therapy! Journal club: nature.com/articles/s4158…

Congrats to Saskia on her successful PhD defense! One of the pioneers of our antibody subgroup and a great person and scientist!

Weekly seminar Results colloquium from Malte Ohlmeyer on modulation of T cell function by costimulatory and coinhibitory molecules during continuous application of T cell recruiting constructs for treatment of B cell malignancies. Journal club: thelancet.com/journals/lance…

Weekly seminar Great results colloquium from @antoniosnews on generation of protective anti-viral immunity by the effective immunopriming of yellow fever vaccine virus! Journal club: nature.com/articles/s4146…

Thank you to the organizers and speakers for making the #itoc7 an amazing virtual conference! @ITOCconference

Check out the poster by our PhD candidate @AnneMarieSenz on how IDO1-deleted CAR T cells show improved therapeutic efficacy in murine pancreatic cancer models @ITOCconference @LMU_Uniklinikum @LMU_Muenchen @iTarget_ENB #Immunotherapy #CARTcells #IDO1 #PancreaticCancer

Welcome to the 7th Immunotherapy of Cancer Virtual Conference! Join us for our welcome address itoc2020.h82.eu

Excited to hear about Synthetic agonistic receptor-activating BiTEs - a modular platform for the efficient targeting of acute myeloid leukemia from M.Res. Mohamed-Reda Benmebarek @BenmebarekMr on Saturday at @ITOCconference @LMU_Uniklinikum @LMU_Muenchen #Immunotherapy #leukemia

Check out the poster from our medical student Carlotta Rambuscheck: Exploring tumor-intrinsic factors regulating the recruitment of myeloid-derived suppressor cells (MDSC) in pancreatic ductal adenocarcinoma. Coming soon at @ITOCconference @LMU_Muenchen @LMU_Uniklinikum #ITOC7

Excited to hear Dr. Daniel Böhmer talk on how Gemcitabine induces pro-apoptotic BH3 only proteins and sensitizes pancreatic ductal adenocarcinoma cells for RLH-triggered immunogenic cell death @ITOCconference @LMU_Uniklinikum #PancreaticCancer #Immunotherapy #ITOC7 #CancerTherapy

Check out the poster from Dr. Bruno L. Cadilha @bcadilha : C-C chemokine receptor 8 tumor-directed recruitment enables CAR T cells to reject solid tumors. Coming soon @ITOCconference @LMU_Uniklinikum @LMU_Muenchen #Immunotherapy #CARTcells #ITOC7 #CancerTherapy

Looking forward to Prof. Dr. Sebastian Kobolds talk on why adoptive T cells therapies fail for solid tumors. @ITOCconference on Saturday 3rd of October #Immunotherapy #cancerresearch #ITOC7 itoc-conference.eu/programme

One Week To Go! Join us for the ITOC7 Virtual Conference on Friday, October 2 and Saturday, October 3, 2020! itoc-conference.eu